Skip to main content
. 2014 Sep 15;8:248. doi: 10.3389/fncel.2014.00248

Figure 1.

Figure 1

Hearing loss in neomycin-treated WT mice. (A) ABR measurements of WT mice 2 weeks after the last injection of neomycin or saline (control). Neomycin or saline was injected once daily between P1 and P7 (Group 1) (A1), P8 and P14 (Group 2) (A2), P15 and P21 (Group 3) (A3), or P60 and P66 (Group 4) (A4). (B) ABR threshold shifts of neomycin-treated samples compared to control. **p < 0.01 vs. control, n = 6–7.